The Global Extracellular Matrix Market is expected to reach US$ 47.46 Mn in 2027
According to a new market research study titled ‘Extracellular Matrix Market to 2027 – Global Analysis and Forecasts by Application, Raw Material andGeography. The Global Extracellular Matrix Market is expected to reach US$ 47.46 Mn in 2027 from US$ 24.30 Mn in 2018. The market is estimated to grow with a CAGR of 8.2% from 2019-2027. The report highlights the trends prevalent in the global extracellular matrix market and the factors driving the market along with those that act as challenges to its growth.
The market for extracellular matrix is expected to grow significantly due to factors such as significantly increasing incidences of trauma and cardiovascular diseases, increasing vascular reconstruction procedures and increasing product launches are likely to drive the growth of the extracellular matrix market. However, challenges during the usage of decellularized extracellular matrix is major challenge for the growth of the extracellular matrix market.
Get PDF sample copy: https://www.theinsightpartners.com/sample/TIPRE00004925/
The major players operating in the extracellular matrix market include, Admedus, Coloplast Group, Merck KGaA, Smith & Nephew, MTF Biologics, Lattice Biologics Ltd., COOK BIOTECH, INC., Medtronic, Aziyo Biologics, Inc., and DSM Biomedical. The market has carried out various organic and inorganic growth strategies in the market which has assisted in strengthening their product offering in the market.
Soft tissue repair segment is expected to grow the market for extracellular matrix over the forecast period by application segment.
Global extracellular matrix market was segmented by application and raw material. On the basis of the application the market is segmented as vascular repair and reconstruction, dural repair, wound healing, cardiac repair, pericardial repair and soft tissue repair. Based on the raw material the extracellular matrix market is segmented into bovine, porcine and others. Among the application segment soft tissue repair market held the largest market share. And on the basis of the raw material porcine segment held the largest market share.
Inquire for Discount: https://www.theinsightpartners.com/discount/TIPRE00004925/
Organic and inorganic growth strategies were observed in global extracellular matrix industry. The organic strategies which were conducted more compared to the inorganic strategies for the extracellular matrix. For instance, in March, 2019, MTF Biologics launched CartiMax Viable Cartilage, for easily filling the lesions in the knee, foot and ankle. The launch demonstrates stable viability post-cryopreservation and provides the clinical benefits of, viable cartilage matrix with live cells. Thus, the organic strategy has enabled the company to grow its business in the market.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Email: [email protected]